**Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Although the benchmark indices opened higher, they traded on a positive note throughout the session and ultimately closed green.
Indian equity benchmarks indices, Sensex and Nifty50 ended higher for the second session as oil prices remained under pressure and IT shares surged.
At the closing bell, the BSE Sensex closed 417 points higher (up 0.5%)
Meanwhile, the NSE Nifty closed 149 points higher (up 0.6%)
You can also visit our live blog section for real-time updates and deeper insights into the market.
TCS, Tech Mahindra, Bharti Airtel are the top gainers today.
Bharat Elec, ITC, Kotak Mahindra on the other hand, were among the top losers today.
The GIFT Nifty was trading at 22,984 with 361 points higher at the time of writing.
The BSE 150 Midcap index is trading 0.05% higher and the BSE 250 SmallCap index is trading 0.06% lower.
Sectoral indices traded mixed today, with buying interest witnessed in the stocks of IT sector and telecommunication sector. Meanwhile, stocks in oil & gas sector and banking sector witnessed selling pressure.
Now track the biggest movers of the stock market using stocks to watch today section. This should help you keep updated with the latest developments...
The rupee is trading at Rs 94.9 against the US$.
Gold prices for the latest contract on MCX are trading 0.6% higher at Rs 1,48,400 per 10 grams.
Meanwhile, silver prices were trading 1.3% higher at 2,13,397 per 1 kg.
Speaking of stock markets, Tanushree Banerjee, Research Analyst at Equitymaster, highlights that Indian IT companies are moving from debt-free balance sheets toward moderate leverage to fund AI-led growth and acquisitions.
Companies are deploying cash and debt for AI infrastructure, cybersecurity and strategic acquisitions. This shift could impact future dividends and buybacks, making debt levels and cash-flow strength key factors for investors.
Watch the video below to know more.
Shares of Angel One came into focus after the company reported its Q2 FY27 results.
Angel One reported a 45% quarter-on-quarter increase in consolidated net profit to Rs 3,350 million in Q2FY27, compared with Rs 2,310 million in the preceding quarter.
Revenue remained largely stable at Rs 14,270 million, against Rs 14,300 million in Q1FY27. EBITDA rose 31% quarter-on-quarter to Rs 6,360 million from Rs 4,850 million, while the EBITDA margin improved to 44.6% from 33.9%.
The company's average client funding book reached a record Rs 74,500 million in Q2FY27, marking a 40.5% year-on-year increase. Credit distribution also recorded strong growth, with disbursements rising 51.8% year-on-year to Rs 6,900 million during the quarter. Monthly credit distribution touched an all-time high of nearly Rs 2,800 million in September 2026.
However, unique systematic investment plan (SIP) registrations declined 19% year-on-year to 1.9 million in Q2FY27. In the wealth management segment, assets under management (AUM) surged 160.5% year-on-year to Rs 160,000 million, while the company's wealth management client base exceeded 2,975 as of September 2026.
Angel One's asset management business reported AUM of Rs 5,700 million at the end of September 2026, representing a 41.3% increase from the corresponding period last year.
Separately, the stockbroking firm announced a second interim dividend of Rs 1.40 per equity share of face value Rs 1 for FY27. The dividend announcement was made on Thursday, 15 October, alongside the company's financial results for the quarter ended 30 September 2026.

Shares of Solara Active Pharma came into focus after the company reported its Q2 FY27 results.
Solara Active Pharma Sciences reported a turnaround in its consolidated earnings for the second quarter of FY27, posting a net profit of Rs 285.9 million for the quarter ended September 2026, compared with a net loss of Rs 92.9 million in the corresponding quarter last year.
According to the company's exchange filing, the consolidated results include the financial performance of the parent company and its three subsidiaries. These comprise two wholly owned subsidiaries, Shasun USA Inc and Synthix Global Pharma Solutions, and another subsidiary, Chemsynth Laboratories Private Limited.
The company's total consolidated income rose 33.1% year-on-year to Rs 4,178.8 million in Q2FY27, from Rs 3,140.3 million in Q2FY26.
To know what's moving the Indian stock markets today check out the most recent share market updates here.
Read the latest Market Commentary
Image source: Chunumunu/www.istockphoto.com
Equitymaster requests your view! Post a comment on "Sensex Today Ends 417 Points Higher | Nifty Above 23,100 | Solara Active Pharma Sciences Up 9%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!